AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Nucana Stock Plunges 63% on Direct Offering
Generated by AI AgentAinvest Movers Radar
Tuesday, May 6, 2025 9:00 am ET1min read
On May 6, 2025, Nucana's stock experienced a significant drop of 63% in pre-market trading, marking a dramatic shift in investor sentiment towards the biopharmaceutical company.
Nucana recently announced a registered direct offering, which included 10,845,985 American Depository Shares (ADSs) or pre-funded warrants. Each ADS or pre-funded warrant was accompanied by Series A and Series B warrants, with the combined public offering price set at $0.6454. The proceeds from this offering, expected to be around $7 million, are intended to support the company's drug discovery and development programs, as well as other general corporate purposes.
The offering is expected to close on or around May 7, 2025, subject to customary closing conditions. Laidlaw & Company (UK) Ltd. is acting as the sole placement agent for the offering. This move by
is part of its broader strategy to advance its pipeline of cancer treatments, including NUC-7738 and NUC-3373, which are currently in various stages of clinical trials.
Ainvest Movers Radar
Knowing stock market today at a glance
Latest Articles
Two Harbors (TWO) Surges 1.59% to Monthly High Amid Anticipation of $1.3B UWM Acquisition
Dec.19 2025
Trane Technologies Surges 1.46% on Q3 Earnings, Analysts Target $550
Dec.19 2025
Rivian (RIVN) Surges 27.34% on Analyst Upgrades, Q3 Revenue Growth Drives Rebound
Dec.19 2025
Tata Chemicals Share Price Soars 119.32% on Novabay Acquisition Drive
Dec.19 2025
X3 Holdings (XTKG) Rallies 36.76% Intraday, 22.50% in Three Sessions on Technical Rebound and Speculative Buying
Dec.19 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet